Natco Pharma to launch 10 new products in India in near term
Hyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday. "Our strategy remains intact as we invest prudently in our research, manufacturing plants and enriching of skill sets. We are on track on our goal to launch 8-10 new products every year across our pharma business segments in India. We also have...
Hyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday.
"Our strategy remains intact as we invest prudently in our research, manufacturing plants and enriching of skill sets. We are on track on our goal to launch 8-10 new products every year across our pharma business segments in India. We also have some interesting filings and high-value launches in our international markets in the coming years," VC Nannapaneni, chairman of the company said in his speech at the Annual General Meeting.
During the year, Natco spent Rs 349 crore on capital expenditure, a majority of which was used to enhance capabilities of their manufacturing facilities. A significant portion of the capex was done at the company''s facility in Visakhapatnam in Andhra Pradesh while the remaining part was primarily used in the formulation facilities across the country, he said.
Read also: Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd